Sulfonamide hypersensitivity syndrome is similar to anticonvulsant hypersensitivity syndrome, but the onset is often sooner in the treatment course, generally after 7–14 days of therapy.[1]: 118–9
It is considered immune-mediated.[2]
This cutaneous condition article is a stub. You can help Wikipedia by expanding it.